PuSH - Publication Server of Helmholtz Zentrum München

19 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Aslibekyan, S.* et al.: Association of methylation signals with incident coronary heart disease in an epigenome-wide assessment of circulating tumor necrosis factor. JAMA Cardiol. 3, 463-472 (2018)
Ligthart, S.* et al.: Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. Am. J. Hum. Genet. 103, 691-706 (2018)
Tönjes, A.* et al.: Genome-wide meta-analysis identifies novel determinants of circulating serum progranulin. Hum. Mol. Genet. 27, 546-558 (2018)
Wheeler, E.* et al.: Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS Med. 14:e1002383 (2017)
Krueger, J.* et al.: Genome wide meta-analysis identifies novel regulators of circulating serum progranulin. Diabetologia 59, S176-S177 (2016)
Ligthart, S.* et al.: DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol. 17:255 (2016)
Marzi, C. et al.: Epigenetic signatures at AQP3 and SOCS3 engage in low-grade inflammation across different tissues. PLoS ONE 11:e0166015 (2016)
Grallert, H. ; Marzi, C. ; Hauck, S.M. & Gieger, C.: Omics: Potential role in early-phase drug development. In: Krentz, A.J.* ; Heinemann, L.* ; Hompesch, M.* [Eds.]: Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development. London: Springer, 2015. 189-222
Tönjes, A.* et al.: Genome wide meta-analysis highlights the role of genetic variation in RARRES2 in the regulation of circulating serum chemerin. PLoS Genet. 10:e1004854 (2015)
Zeller, T.* et al.: Molecular characterization of the NLRC4 expression in relation to interleukin-18 levels. Circ. Cardiovasc. Genet. 8, 717-726 (2015)
Breitfeld, J.* et al.: Genome wide meta-analysis highlights the role of genetic variation in RARRES2 in regulation of circulating serum chemerin. Diabetologia 57, S67-S68 (2014)
Ellis, J.* et al.: Large multiethnic candidate gene study for C-reactive protein levels: Identification of a novel association at CD36 in African Americans. Hum. Genet. 133, 985-995 (2014)
Herder, C.* et al.: Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits. Diabetes 63, 4343-4359 (2014)
Schramm, K. et al.: Mapping the genetic architecture of gene regulation in whole blood. PLoS ONE 9:e93844 (2014)
Breitfeld, J.* et al.: Genetic variation in the vaspin gene affects circulating serum vaspin concentrations. Int. J. Obes. 37, 861-866 (2013)
Marzi, C. et al.: Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study. Diabetes Care 36, 1321-1326 (2013)
Grallert, H. et al.: Association of genetic variation in KCNQ1 with type 2 diabetes in the KORA surveys. Horm. Metab. Res. 42, 149-151 (2010)
Marzi, C. et al.: Genome-wide association study identifies two novel regions at 11p15.5-p13 and 1p31 with major impact on acute-phase serum amyloid A. PLoS Genet. 6:e1001213 (2010)
Marzi, C.* et al.: Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. Horm. Metab. Res. 39, 46-52 (2007)